NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
about
The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysisAssociation between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjectsBiological interaction of cigarette smoking on the association between genetic polymorphisms involved in inflammation and the risk of lung cancer: A case-control study in Japan.NQO1 C609T polymorphism and lung cancer susceptibility: Evidence from a comprehensive meta-analysis.Significant benefit of Nivolumab treating PD-L1 positive metastatic pulmonary carcinosarcoma: a case report and literature review.
P2860
NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
NAD(P)H: quinone oxidoreductas ...... cancer risk: a meta-analysis.
@en
type
label
NAD(P)H: quinone oxidoreductas ...... cancer risk: a meta-analysis.
@en
prefLabel
NAD(P)H: quinone oxidoreductas ...... cancer risk: a meta-analysis.
@en
P2093
P2860
P1433
P1476
NAD(P)H: quinone oxidoreductas ...... cancer risk: a meta-analysis.
@en
P2093
Baohui Han
Chunlei Shi
Liwen Xiong
Shaojun Wen
Tianqing Chu
Xueyan Zhang
P2860
P2888
P304
P356
10.1007/S13277-013-0985-7
P577
2013-07-14T00:00:00Z